PortalPublikationenDarbepoetin improves endothelial function and increases circ...

Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease.

Standard

Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease. / Mueller, Cornelius; Wodack, Karin; Twelker, Kaja; Werner, Nikos; Custodis, Florian; Nickenig, Georg.

in: HEART, Jahrgang 97, Nr. 18, 18, 2011, S. 1474-1478.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Mueller, C, Wodack, K, Twelker, K, Werner, N, Custodis, F & Nickenig, G 2011, 'Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease.', HEART, Jg. 97, Nr. 18, 18, S. 1474-1478. <http://www.ncbi.nlm.nih.gov/pubmed/21719555?dopt=Citation>

APA

Mueller, C., Wodack, K., Twelker, K., Werner, N., Custodis, F., & Nickenig, G. (2011). Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease. HEART, 97(18), 1474-1478. [18]. http://www.ncbi.nlm.nih.gov/pubmed/21719555?dopt=Citation

Vancouver

Mueller C, Wodack K, Twelker K, Werner N, Custodis F, Nickenig G. Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease. HEART. 2011;97(18):1474-1478. 18.

Bibtex

@article{1d6bee122ac04e6995f808dc7e3f9db9,
title = "Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease.",
abstract = "Atherosclerosis is a progressive disease characterised in part by an imbalance of endothelial decline and endothelial repair. Erythropoietin has been connected to vasculoprotective effects such as enhanced nitric oxide production in endothelial cells and mobilisation of endothelial progenitor cells (EPC).",
keywords = "Humans, Male, Aged, Female, Middle Aged, Prospective Studies, Flow Cytometry, Coronary Disease/*drug therapy/pathology/physiopathology, Endothelial Cells/*drug effects, Endothelium, Vascular/drug effects/*physiology, Erythropoietin/*therapeutic use, Recombinant Proteins/therapeutic use, Stem Cells/drug effects, Humans, Male, Aged, Female, Middle Aged, Prospective Studies, Flow Cytometry, Coronary Disease/*drug therapy/pathology/physiopathology, Endothelial Cells/*drug effects, Endothelium, Vascular/drug effects/*physiology, Erythropoietin/*therapeutic use, Recombinant Proteins/therapeutic use, Stem Cells/drug effects",
author = "Cornelius Mueller and Karin Wodack and Kaja Twelker and Nikos Werner and Florian Custodis and Georg Nickenig",
year = "2011",
language = "English",
volume = "97",
pages = "1474--1478",
journal = "HEART",
issn = "1355-6037",
publisher = "BMJ PUBLISHING GROUP",
number = "18",

}

RIS

TY - JOUR

T1 - Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease.

AU - Mueller, Cornelius

AU - Wodack, Karin

AU - Twelker, Kaja

AU - Werner, Nikos

AU - Custodis, Florian

AU - Nickenig, Georg

PY - 2011

Y1 - 2011

N2 - Atherosclerosis is a progressive disease characterised in part by an imbalance of endothelial decline and endothelial repair. Erythropoietin has been connected to vasculoprotective effects such as enhanced nitric oxide production in endothelial cells and mobilisation of endothelial progenitor cells (EPC).

AB - Atherosclerosis is a progressive disease characterised in part by an imbalance of endothelial decline and endothelial repair. Erythropoietin has been connected to vasculoprotective effects such as enhanced nitric oxide production in endothelial cells and mobilisation of endothelial progenitor cells (EPC).

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Flow Cytometry

KW - Coronary Disease/drug therapy/pathology/physiopathology

KW - Endothelial Cells/drug effects

KW - Endothelium, Vascular/drug effects/physiology

KW - Erythropoietin/therapeutic use

KW - Recombinant Proteins/therapeutic use

KW - Stem Cells/drug effects

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Flow Cytometry

KW - Coronary Disease/drug therapy/pathology/physiopathology

KW - Endothelial Cells/drug effects

KW - Endothelium, Vascular/drug effects/physiology

KW - Erythropoietin/therapeutic use

KW - Recombinant Proteins/therapeutic use

KW - Stem Cells/drug effects

M3 - SCORING: Journal article

VL - 97

SP - 1474

EP - 1478

JO - HEART

JF - HEART

SN - 1355-6037

IS - 18

M1 - 18

ER -